Search

01/04/2024 Validation of the Artificial Intelligence Prognostic Scoring System for Myelodysplastic Syndromes in chronic myelomonocytic leukaemia: A novel approach for improved risk stratification
Orgueira, AM, Encinas, MMP, Varela, ND, Wang, YH, Mora, E, Diaz-Beya, M, Montoro, MJ, Marin, HP, Ortega, FR, Tormo, M, Jerez, A, Nomdedeu, J, Sanchez, CD, Arenillas, L, Carcel, P, Romero, MTC, Cirici, BX, Arango, ER, Barreto, RAD, Benlloch, L, Lin, CC, Tien, HF, Míguez, CP, Crucitti, D, Campelo, MD, Valcárcel, D. Validation of the Artificial Intelligence Prognostic Scoring System for Myelodysplastic Syndromes in chronic myelomonocytic leukaemia: A novel approach for improved risk stratification. BRITISH JOURNAL OF HAEMATOLOGY. 2024; 204(4)DOI:10.1111/bjh.19341. PMID:38411250. IF:3.800(Q1/3D).
01/10/2023 Machine Learning Improves Risk Stratification in Myelodysplastic Neoplasms: An Analysis of the Spanish Group of Myelodysplastic Syndromes
Orgueira, AM, Encinas, MMP, Varela, NAD, Mora, E, Díaz-Beyá, M, Montoro, MJ, Pomares, H, Ramos, F, Tormo, M, Jerez, A, Nomdedeu, JF, Sanchez, CD, Leonor, A, Cárcel, P, Romero, MTC, Xicoy, B, Rivero, E, Barreto, RAD, Diez-Campelo, M, Benlloch, LE, Crucitti, D, Valcárcel, D. Machine Learning Improves Risk Stratification in Myelodysplastic Neoplasms: An Analysis of the Spanish Group of Myelodysplastic Syndromes. Hemasphere. 2023; 7(10)DOI:10.1097/HS9.0000000000000961. PMID:37841754. IF:11.900(Q1/1D).
01/08/2023 Incidence and prognostic impact of U2AF1 mutations and other gene alterations in myelodysplastic neoplasms with isolated 20q deletion
Castillo M.I., Ribate V.E., Muñoz C.M., Santillana S.G., Taboada S.E., Casterá M.E., Abinzano C.M.J., Barranco I.A., Nieto C.R., Pampliega V.M., Blanco M.L., de Andrés Á.S., de Oteyza P.J., del Castillo B.T., Font G.I., Cayuela J.A., Díez-Campelo M., Sánchez A.R., Vercet S.C., Díaz T.M.. Incidence and prognostic impact of U2AF1 mutations and other gene alterations in myelodysplastic neoplasms with isolated 20q deletion. Cancer Medicine. 2023; 12(16)DOI:10.1002/cam4.6300. PMID:37403747. IF:2.900(Q2/5D).
01/01/2023 Machine Learning Improves Risk Stratification in Myelofibrosis: An Analysis of the Spanish Registry of Myelofibrosis
Mosquera-Orgueira, A, Perez-Encinas, M, Hernandez-Sanchez, A, Gonzalez-Martinez, T, Arellano-Rodrigo, E, Martinez-Elicegui, J, Villaverde-Ramiro, A, Raya, JM, Ayala, R, Ferrer-Marin, F, Fox, ML, Velez, P, Mora, E, Xicoy, B, Mata-Vazquez, MI, Garcia-Fortes, M, Angona, A, Cuevas, B, Senin, MA, Ramirez-Payer, A, Ramirez, MJ, Perez-Lopez, R, de Villambrosia, SG, Martinez-Valverde, C, Gomez-Casares, MT, Garcia-Hernandez, C, Gasior, M, Bellosillo, B, Steegmann, JL, Alvarez-Larran, A, Hernandez-Rivas, JM, Hernandez-Boluda, JC. Machine Learning Improves Risk Stratification in Myelofibrosis: An Analysis of the Spanish Registry of Myelofibrosis. Hemasphere. 2023; 7(1)DOI:10.1097/HS9.0000000000000818. PMID:36570691. IF:11.900(Q1/1D).
01/01/2023 Epigenome profiling reveals aberrant DNA methylation signature in GATA2 deficiency
Marin-Bejar O., Romero-Moya D., Rodriguez-Ubreva J., Distefano M., Lessi F., Aretini P., Liquori A., Castaño J., Kozyra E., Kotmayer L., Bueno C., Cervera J., Rodriguez-Gallego J.C., Nomdedeu J.F., Murillo-Sanjuán L., De Heredia C.D., Pérez-Martinez A., López-Cadenas F., Martínez-Laperche C., Dorado-Herrero N., Marco F.M., Prósper F., Menendez P., Valcárcel D., Ballestar E., Bödör C., Bigas A., Catalá A., Wlodarski M.W., Giorgetti A.. Epigenome profiling reveals aberrant DNA methylation signature in GATA2 deficiency. HAEMATOLOGICA. 2023; 108(9)DOI:10.3324/haematol.2022.282305. PMID:36815365. IF:10.100(Q1/2D).
11/08/2022 Clinical, histological and molecular profiling of different stages of alcohol-related liver disease
Ventura-Cots, M, Argemi, J, Jones, PD, Lackner, C, El Hag, M, Abraldes, JG, Alvarado, E, Clemente, A, Ravi, S, Alves, A, Alboraie, M, Altamirano, J, Barace, S, Bosques, F, Brown, R, Caballeria, J, Cabezas, J, Carvalhana, S, Cortez-Pinto, H, Costa, A, Degre, D, Fernandez-Carillo, C, Ganne-Carrie, N, Garcia-Tsao, G, Genesca, J, Koskinas, J, Lanthier, N, Louvet, A, Lozano, JJ, Lucey, MR, Masson, S, Mathurin, P, Mendez-Sanchez, N, Miquel, R, Moreno, C, Mounajjed, T, Odena, G, Kim, W, Sancho-Bru, P, Sands, RW, Szafranska, J, Verset, L, Schnabl, B, Sempoux, C, Shah, VJ, Shawcross, DL, Stauber, RE, Straub, BK, Verna, E, Tiniakos, D, Trepo, E, Vargas, V, Villanueva, C, Woosley, JT, Ziol, M, Mueller, S, Starkel, P, Bataller, R. Clinical, histological and molecular profiling of different stages of alcohol-related liver disease. GUT. 2022; 71(9)DOI:10.1136/gutjnl-2021-324295. PMID:34992134. IF:24.500(Q1/1D).
03/07/2022 Multimodality imaging evaluation of a primary cardiac epithelioid hemangioendothelioma
Marsico, S, Orellana-Fernandez, R, Tizon-Marcos, H, Mas-Stachurska, A, Solano, A, Zuccarino, F. Multimodality imaging evaluation of a primary cardiac epithelioid hemangioendothelioma. ACTA CARDIOLOGICA. 2022; 77(6)DOI:10.1080/00015385.2021.1908704. PMID:33827376. IF:1.600(Q4/9D).
01/02/2022 Urinary Proteomic Signature in Acute Decompensated Heart Failure: Advances into Molecular Pathophysiology
Diaz-Riera, E, Garcia-Arguinzonis, M, Lopez, L, Garcia-Moll, X, Badimon, L, Padro, T. Urinary Proteomic Signature in Acute Decompensated Heart Failure: Advances into Molecular Pathophysiology. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2022; 23(4)DOI:10.3390/ijms23042344. PMID:35216460. IF:5.600(Q1/3D).